- Home
- HRTX vs BGH Comparison
HRTX vs BGH Comparison
Compare HRTX & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- BGH
- Stock Information
- Founded
- HRTX 1983
- BGH 2012
- Country
- HRTX United States
- BGH United States
- Employees
- HRTX N/A
- BGH N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- BGH Investment Managers
- Sector
- HRTX Health Care
- BGH Finance
- Exchange
- HRTX Nasdaq
- BGH Nasdaq
- Market Cap
- HRTX 276.1M
- BGH 318.8M
- IPO Year
- HRTX 1987
- BGH N/A
- Fundamental
- Price
- HRTX $1.35
- BGH $16.37
- Analyst Decision
- HRTX Strong Buy
- BGH
- Analyst Count
- HRTX 2
- BGH 0
- Target Price
- HRTX $4.50
- BGH N/A
- AVG Volume (30 Days)
- HRTX 2.6M
- BGH 61.5K
- Earning Date
- HRTX 08-08-2025
- BGH 01-01-0001
- Dividend Yield
- HRTX N/A
- BGH 10.06%
- EPS Growth
- HRTX N/A
- BGH N/A
- EPS
- HRTX N/A
- BGH N/A
- Revenue
- HRTX $149,694,000.00
- BGH N/A
- Revenue This Year
- HRTX $10.62
- BGH N/A
- Revenue Next Year
- HRTX $12.99
- BGH N/A
- P/E Ratio
- HRTX N/A
- BGH N/A
- Revenue Growth
- HRTX 9.78
- BGH N/A
- 52 Week Low
- HRTX $1.04
- BGH $11.92
- 52 Week High
- HRTX $2.68
- BGH $14.50
- Technical
- Relative Strength Index (RSI)
- HRTX 36.48
- BGH 63.33
- Support Level
- HRTX $1.33
- BGH $15.76
- Resistance Level
- HRTX $1.43
- BGH $16.43
- Average True Range (ATR)
- HRTX 0.07
- BGH 0.14
- MACD
- HRTX 0.02
- BGH -0.00
- Stochastic Oscillator
- HRTX 45.45
- BGH 91.04
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.